Diabetes Core Update Nov 2025
This issue will review:
1. Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis - Diabetes Care
2. Orforglipron, an Oral Small-Molecule GLP-1Receptor Agonist, in Early Type 2 Diabetes – NEJM
3. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment – NEJM
4. Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors – Diabetes Care
5. Impact of baseline GLP-1 Receptor Agonist Use on Albuminuria Reduction…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.